Eiichi Sato: Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
Atsushi Togawa: Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
Michio Masaki: Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
Akihiko Shirahashi: Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
Midori Kumagawa: Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
Yasumasa Kawano: Department of Emergency and Critical Care Medicine, Fukuoka University Hospital, Japan.
Hiroyasu Ishikura: Department of Emergency and Critical Care Medicine, Fukuoka University Hospital, Japan.
Yuri Yamashiro: Department of Plastic and Reconstructive Surgery, Fukuoka University Hospital, Japan.
Satoshi Takagi: Department of Plastic and Reconstructive Surgery, Fukuoka University Hospital, Japan.
Hiromi To: Department of Clinical Laboratory Medicine, Fukuoka University Hospital, Japan.
Katsumi Kobata: Department of Pathology, Fukuoka University Hospital, Japan.
Morishige Takeshita: Department of Pathology, Fukuoka University Hospital, Japan.
Koji Kusaba: Department of Laboratory Medicine, Saga University Hospital, Japan.
Eisaburo Sueoka: Department of Laboratory Medicine, Saga University Hospital, Japan.
Kazuo Tamura: Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
Yasushi Takamatsu: Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
Tohru Takata: Division of Medical Oncology, Hematology, and Infectious Diseases, Department of Internal Medicine, Fukuoka University Hospital, Japan.
We herein report a case of systemic phaeohyphomycosis by Exophiala dermatitidis (E. dermatitidis) with chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (HSCT). The patient had been taking oral corticosteroids for years to control the GVHD. Yeast-like fungi were identified in a blood culture, so treatment with micafungin (150 mg/day) was begun, with no improvement. The patient passed away on hospital Day 12. A sequence analysis of rRNA revealed the isolate to be E. dermatitidis. This report brings attention to an emerging Mycosis of community-acquired Exophiala species infection in the very-late phase after allogenic HSCT in patients with chronic GVHD.